Personalized medicine for cancer: from molecular signature to therapeutic choice.
Sikora
Karol
K
Faculty of Medicine, Hammersmith Hospital Imperial College, London, United Kingdom.
D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use; D014408:Biomarkers, Tumor; D015195:Drug Design; D006801:Humans; D008403:Mass Screening; D025202:Molecular Diagnostic Techniques / Q000379:methods / Q000639:trends*; D009369:Neoplasms / Q000175:diagnosis* / Q000188:drug therapy / Q000517:prevention & control*
D000970:Antineoplastic Agents; D014408:Biomarkers, Tumor